Upcoming code Effective Jan 1, 2027
Ranluspec Q Code: Q5177
Injection, ranibizumab-hkdz, biosimilar, 0.1 mg
Effective Date
Jan 1, 2027
Q1 2027 · not billable before Medicare Payment Limit
Not yet published
CMS hasn’t priced Q5177 yet CMS Decision
New code
Third Quarter 2026 Billing Unit
0.1 mg
per HCPCS unit · from the CMS descriptor NDCs
Not yet listed
Listed once CMS crosswalks Q5177 Upcoming HCPCS Code · Effective January 1, 2027 CMS established Q5177 in its Third Quarter 2026 HCPCS coding cycle. It is not valid on claims with dates of service before January 1, 2027. CMS has not yet published a payment limit for Q5177.
Source: CMS HCPCS Application Summary, Third Quarter 2026 (PDF) . Code decisions are CMS’s; this page tracks them until the code takes effect.